Hepatitis delta: Seek and ye shall find

Journal of Infectious Diseases

Volumn 202, Issue 6, 2010, Pages 822-824

  Holmberg, Scott D ^a   Ward, John W ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

DELTA AGENT HEPATITIS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; INTRAVENOUS DRUG ABUSE; MIXED INFECTION; NOTE; PRIORITY JOURNAL; VIRUS TRANSMISSION;

ANIMALS; COMORBIDITY; FEMALE; HEPATITIS D; HEPATITIS DELTA VIRUS; HUMANS; MALE; SEROEPIDEMIOLOGIC STUDIES; SUBSTANCE ABUSE, INTRAVENOUS; UNITED STATES;

EID: 77955946840     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/655809     Document Type: Note

References (22)

1. Rizzetto M, Canese MG, Gerin JL, et al. Immunofluorescence detection of new antigenantibody system (delta/anti-delta) associated to hepatitis B virus in liver and serum of HBsAg carriers. Gut 1977; 18(12):997-1003.
2. Rizzetto M. Hepatitis D: thirty years after [review]. J Hepatol 2009; 50:1043-1050.
3. Taylor JM. Hepatitis delta virus. Virology 2006; 344:71-76.
4. Wedemeyer H. Re-emerging interest in hepatitis delta: new insights into the dynamic interplay between HBV and HDV. J Hepatol 2010; 52(5):627-629.
5. Kucirka LM, Farzadegan H, Field JJ, et al. Prevalence, correlates, and viral dynamics of hepatitis delta among injection drug users. J Infect Dis 2010; 202(6):845-852 (in this issue).
6. Rizzetto M. Hepatitis D: the comeback? Liver Int 2009; 29:140-142.
7. Nath N, Mushawar IK, Fang CT, BerberianH, Dodd RY. Antibodies to delta antigen in asymptomatic hepatitis B surface antigen-reactive blood donors in the United States and their association with other markers of hepatitis B virus. Am J Epidemiol 1985; 122:218-225.
8. De Cock KM, Niland JC, Lu HP, et al. Experience with human immunodeficiency virus infection in patients with hepatitis B virus and hepatitis delta virus infections in Los Angeles, 1977-1985. Am J Epidemiol 1988; 127:1250-1260.
9. Govindarajan S, Kanel GC, Peters RL. Prevalence of delta-antibody among chronic hepatitis B virus infected patients in the Los Angeles area: its correlation with liver biopsy diagnosis. Gastroenterology 1983; 85:160-162.
10. Hershow RC, Chomel BB, Graham DR, et al. Hepatitis D virus infection in Illinois state facilities or the developmentally disabled: epidemiology and clinical manifestations. Ann Intern Med 1989; 110:779-785.
11. Novick DM, Farci P, Croxson TS, et al. Hepatitis D virus and human immunodeficiency virus antibodies in parenteral drug abusers who are hepatitis B surface antigen positive. J Infect Dis 1988; 158:795-803.
12. Ponzetto A, Seeff LB, Buskell-Bales Z, et al. Hepatitis B markers in United States drug addicts with special emphasis on the delta hepatitis virus. Hepatology 1984; 4:1111-1115.
13. Lettau LA, McCarthy JG, Smith MH, et al.Outbreak of severe hepatitis due to delta and hepatitis B viruses in parenteral drug abusers and their contacts. N Engl J Med 1987; 317: 1256-1262.
14. Bialek SR, Bower WA, Mottram K, et al. Risk factors for hepatitis B in an outbreak of hepatitis B and D among injection drug users. J Urban Health 2005; 82:468-478.
15. Rosenblum L, DarrowW,Witte J, et al. Sexual practices in the transmission of hepatitis B virus and prevalence of hepatitis delta virus infection in female prostitutes in the United States. JAMA 1992; 267:2477-2481.
16. Troisi CL, Hollinger FB, Hoots WK, et al. A multicenter study of viral hepatitis in a United States hemophilic population. Blood 1993; 81: 412-418.
17. Weisfuse IB, Hadler SC, Fields HA, et al. Delta hepatitis in homosexual men in the United States. Hepatology 1989; 9:872-874.
18. Daniels D, Grytdal S, Wasley A. Surveillance for acute hepatitis-United States, 2007. MMWR 2009; 58(Suppl 3):1-27
19. Centers for Disease Control and Prevention. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP). Part II: immunization of adults. MMWR Morb Mortal Wkly Rep 2006; 55:1-33.
20. Centers for Disease Control and Prevention. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Morb Mortal Wkly Rep 2008; 57:1-20.
21. Kresina TF, Hoffman K, Lubran R, Clark HW. Integrating hepatitis services into substance abuse treatment programs: new initiatives from SAMHSA. Public Health Rep 2007; 122(Suppl 2):96-98.
22. Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment. Screening for infectious diseases among substance abusers (Treatment Improvement Protocol [TIP] Series 6; DHHS publication[SMA] 95-3060). Rockville, Maryland: NIH, 1993. http://www.ncbi.nlm.nih.gov/bookshelf/ br.fcgi?bookphssamhsatip&partpA25461. Accessed 19 April 2010.